[
  {
    "id": 0,
    "conceptType": "Drug",
    "name": "Brentuximab Vedotin",
    "primaryCoding": "ncit:C66944",
    "mappings": [
      326
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "target CD30 antigens"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 1,
    "conceptType": "Drug",
    "name": "Dacarbazine",
    "primaryCoding": "ncit:C411",
    "mappings": [
      327
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Nonclassical alkylating chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 2,
    "conceptType": "Drug",
    "name": "Doxorubicin",
    "primaryCoding": "ncit:C456",
    "mappings": [
      328
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Topoisomerase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 3,
    "conceptType": "Drug",
    "name": "Vinblastine",
    "primaryCoding": "ncit:C930",
    "mappings": [],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Vinca alkaloid chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 4,
    "conceptType": "Drug",
    "name": "Everolimus",
    "primaryCoding": "ncit:C48387",
    "mappings": [
      330
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PI3K/AKT/mTOR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 5,
    "conceptType": "Drug",
    "name": "Exemestane",
    "primaryCoding": "ncit:C1097",
    "mappings": [
      331
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Aromatase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 6,
    "conceptType": "Drug",
    "name": "Niraparib",
    "primaryCoding": "ncit:C80059",
    "mappings": [
      332
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PARP inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 7,
    "conceptType": "Drug",
    "name": "Abiraterone acetate",
    "primaryCoding": "ncit:C68845",
    "mappings": [
      333
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Antiandrogen"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 8,
    "conceptType": "Drug",
    "name": "Prednisolone",
    "primaryCoding": "ncit:C769",
    "mappings": [
      334
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Corticosteroid"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 9,
    "conceptType": "Drug",
    "name": "Alectinib",
    "primaryCoding": "ncit:C101790",
    "mappings": [
      335
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ALK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 10,
    "conceptType": "Drug",
    "name": "Brigatinib",
    "primaryCoding": "ncit:C98831",
    "mappings": [
      336
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ALK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 11,
    "conceptType": "Drug",
    "name": "Bevacizumab",
    "primaryCoding": "ncit:C2039",
    "mappings": [
      337
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "VEGF inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 12,
    "conceptType": "Drug",
    "name": "Erlotinib",
    "primaryCoding": "ncit:C65530",
    "mappings": [
      338
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 13,
    "conceptType": "Drug",
    "name": "Avapritinib",
    "primaryCoding": "ncit:C123827",
    "mappings": [
      339
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "KIT inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 14,
    "conceptType": "Drug",
    "name": "Inotuzumab ozogamicin",
    "primaryCoding": "ncit:C71542",
    "mappings": [
      340
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "BCR-ABL inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 15,
    "conceptType": "Drug",
    "name": "Blinatumomab",
    "primaryCoding": "ncit:C62528",
    "mappings": [
      341
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "CD19 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 16,
    "conceptType": "Drug",
    "name": "Bosutinib",
    "primaryCoding": "ncit:C60809",
    "mappings": [
      342
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "BCR-ABL inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 17,
    "conceptType": "Drug",
    "name": "Binimetinib",
    "primaryCoding": "ncit:C84865",
    "mappings": [
      343
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "MEK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 18,
    "conceptType": "Drug",
    "name": "Encorafenib",
    "primaryCoding": "ncit:C98283",
    "mappings": [
      344
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "B-RAF inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 19,
    "conceptType": "Drug",
    "name": "Cetuximab",
    "primaryCoding": "ncit:C1723",
    "mappings": [
      345
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 20,
    "conceptType": "Drug",
    "name": "Vandetanib",
    "primaryCoding": "ncit:C2737",
    "mappings": [
      346
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "RET inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 21,
    "conceptType": "Drug",
    "name": "Cobimetinib",
    "primaryCoding": "ncit:C68923",
    "mappings": [
      347
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "MEK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 22,
    "conceptType": "Drug",
    "name": "Vemurafenib",
    "primaryCoding": "ncit:C64768",
    "mappings": [
      348
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "B-RAF inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 23,
    "conceptType": "Drug",
    "name": "Ramucirumab",
    "primaryCoding": "ncit:C70792",
    "mappings": [
      349
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "VEGF/VEGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 24,
    "conceptType": "Drug",
    "name": "Docetaxel",
    "primaryCoding": "ncit:C1526",
    "mappings": [
      350
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Taxane-based chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 25,
    "conceptType": "Drug",
    "name": "Trastuzumab",
    "primaryCoding": "ncit:C1647",
    "mappings": [
      351
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "HER2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 26,
    "conceptType": "Drug",
    "name": "Trastuzumab deruxtecan",
    "primaryCoding": "ncit:C128799",
    "mappings": [
      352
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "HER2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 27,
    "conceptType": "Drug",
    "name": "Irinotecan",
    "primaryCoding": "ncit:C62040",
    "mappings": [
      353
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Topoisomerase I inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 28,
    "conceptType": "Drug",
    "name": "Oxaliplatin",
    "primaryCoding": "ncit:C1181",
    "mappings": [
      354
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Platinum-based chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 29,
    "conceptType": "Drug",
    "name": "Fluorouracil",
    "primaryCoding": "ncit:C505",
    "mappings": [
      355
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Thymidylate synthase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 30,
    "conceptType": "Drug",
    "name": "Fulvestrant",
    "primaryCoding": "ncit:C1379",
    "mappings": [
      356
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Estrogen receptor inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 31,
    "conceptType": "Drug",
    "name": "Palbociclib",
    "primaryCoding": "ncit:C49176",
    "mappings": [
      357
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "CDK4/6 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 32,
    "conceptType": "Drug",
    "name": "Pralsetinib",
    "primaryCoding": "ncit:C132295",
    "mappings": [
      358
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "RET inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 33,
    "conceptType": "Drug",
    "name": "Gefitinib",
    "primaryCoding": "ncit:C1855",
    "mappings": [
      359
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 34,
    "conceptType": "Drug",
    "name": "Afatinib",
    "primaryCoding": "ncit:C66940",
    "mappings": [
      360
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 35,
    "conceptType": "Drug",
    "name": "Paclitaxel",
    "primaryCoding": "ncit:C1411",
    "mappings": [
      361
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Taxane-based chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 36,
    "conceptType": "Drug",
    "name": "Anastrozole",
    "primaryCoding": "ncit:C1607",
    "mappings": [
      362
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Aromatase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 37,
    "conceptType": "Drug",
    "name": "Carboplatin",
    "primaryCoding": "ncit:C1282",
    "mappings": [
      363
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Platinum-based chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 38,
    "conceptType": "Drug",
    "name": "Capecitabine",
    "primaryCoding": "ncit:C1794",
    "mappings": [
      364
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Thymidylate synthase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 39,
    "conceptType": "Drug",
    "name": "Cisplatin",
    "primaryCoding": "ncit:C376",
    "mappings": [
      365
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Platinum-based chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 40,
    "conceptType": "Drug",
    "name": "Letrozole",
    "primaryCoding": "ncit:C1527",
    "mappings": [
      366
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Aromatase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 41,
    "conceptType": "Drug",
    "name": "Imatinib",
    "primaryCoding": "ncit:C62035",
    "mappings": [
      367
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Bcr-Abl inhibition",
          "c-Kit inhibition",
          "PDGF-R inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 43,
    "conceptType": "Drug",
    "name": "Ponatinib",
    "primaryCoding": "ncit:C95777",
    "mappings": [
      369
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "BCR-ABL inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 44,
    "conceptType": "Drug",
    "name": "Durvalumab",
    "primaryCoding": "ncit:C103194",
    "mappings": [
      370
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PD-1/PD-L1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 45,
    "conceptType": "Drug",
    "name": "Tremelimumab",
    "primaryCoding": "ncit:C49085",
    "mappings": [
      371
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "CTLA-4 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 46,
    "conceptType": "Drug",
    "name": "Olaparib",
    "primaryCoding": "ncit:C71721",
    "mappings": [
      372
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PARP inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 47,
    "conceptType": "Drug",
    "name": "Dostarlimab",
    "primaryCoding": "ncit:C126799",
    "mappings": [
      373
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PD-1/PD-L1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 48,
    "conceptType": "Drug",
    "name": "Pembrolizumab",
    "primaryCoding": "ncit:C106432",
    "mappings": [
      374
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PD-1/PD-L1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 49,
    "conceptType": "Drug",
    "name": "Pemetrexed",
    "primaryCoding": "ncit:C61614",
    "mappings": [
      375
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Antifolate"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 50,
    "conceptType": "Drug",
    "name": "Gemcitabine",
    "primaryCoding": "ncit:C66876",
    "mappings": [
      376
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Antimetabolite"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 51,
    "conceptType": "Drug",
    "name": "Nab-paclitaxel",
    "primaryCoding": "ncit:C2688",
    "mappings": [
      377
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Taxane-based chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 52,
    "conceptType": "Drug",
    "name": "Trastuzumab emtansine",
    "primaryCoding": "ncit:C82492",
    "mappings": [
      378
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "HER2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 53,
    "conceptType": "Drug",
    "name": "Ribociclib",
    "primaryCoding": "ncit:C95701",
    "mappings": [
      379
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "CDK4/6 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 54,
    "conceptType": "Drug",
    "name": "Adagrasib",
    "primaryCoding": "ncit:C157493",
    "mappings": [
      380
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "RAS inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 55,
    "conceptType": "Drug",
    "name": "Cemiplimab",
    "primaryCoding": "ncit:C121540",
    "mappings": [
      381
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PD-1/PD-L1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 56,
    "conceptType": "Drug",
    "name": "Lorlatinib",
    "primaryCoding": "ncit:C113655",
    "mappings": [
      382
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ALK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 57,
    "conceptType": "Drug",
    "name": "Sotorasib",
    "primaryCoding": "ncit:C154287",
    "mappings": [
      383
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "RAS inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 58,
    "conceptType": "Drug",
    "name": "Futibatinib",
    "primaryCoding": "ncit:C114283",
    "mappings": [
      384
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "FGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 59,
    "conceptType": "Drug",
    "name": "Cyclophosphamide",
    "primaryCoding": "ncit:C405",
    "mappings": [
      385
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Alkylating chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 60,
    "conceptType": "Drug",
    "name": "Rituximab",
    "primaryCoding": "ncit:C1702",
    "mappings": [
      386
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "CD20 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 61,
    "conceptType": "Drug",
    "name": "Vincristine",
    "primaryCoding": "ncit:C933",
    "mappings": [
      387
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Vinca alkaloid chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 62,
    "conceptType": "Drug",
    "name": "Corticosteroid",
    "primaryCoding": "ncit:C2322",
    "mappings": [
      388
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Anti-inflammatory"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 63,
    "conceptType": "Drug",
    "name": "Cytarabine",
    "primaryCoding": "ncit:C408",
    "mappings": [
      389
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "DNA Polymerase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 64,
    "conceptType": "Drug",
    "name": "Etoposide",
    "primaryCoding": "ncit:C491",
    "mappings": [
      390
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Topoisomerase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 65,
    "conceptType": "Drug",
    "name": "Methotrexate",
    "primaryCoding": "ncit:C642",
    "mappings": [
      391
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Antifolate"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 66,
    "conceptType": "Drug",
    "name": "Trametinib",
    "primaryCoding": "ncit:C77908",
    "mappings": [
      392
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "MEK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 67,
    "conceptType": "Drug",
    "name": "Dabrafenib",
    "primaryCoding": "ncit:C82386",
    "mappings": [
      393
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "B-RAF inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 68,
    "conceptType": "Drug",
    "name": "Daunorubicin",
    "primaryCoding": "ncit:C62091",
    "mappings": [
      394
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "DNA Polymerase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 69,
    "conceptType": "Drug",
    "name": "Gemtuzumab ozogamicin",
    "primaryCoding": "ncit:C1806",
    "mappings": [
      395
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "CD33 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 70,
    "conceptType": "Drug",
    "name": "Neratinib",
    "primaryCoding": "ncit:C49094",
    "mappings": [],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "HER2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 71,
    "conceptType": "Drug",
    "name": "Ipilimumab",
    "primaryCoding": "ncit:C2654",
    "mappings": [
      397
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "CTLA-4 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 72,
    "conceptType": "Drug",
    "name": "Nivolumab",
    "primaryCoding": "ncit:C68814",
    "mappings": [
      398
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PD-1/PD-L1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 73,
    "conceptType": "Drug",
    "name": "Relatlimab",
    "primaryCoding": "ncit:C111999",
    "mappings": [
      399
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "LAG-3 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 74,
    "conceptType": "Drug",
    "name": "Elacestrant",
    "primaryCoding": "ncit:C120211",
    "mappings": [
      400
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ER signaling inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 75,
    "conceptType": "Drug",
    "name": "Pertuzumab",
    "primaryCoding": "ncit:C38692",
    "mappings": [
      401
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "HER2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 76,
    "conceptType": "Drug",
    "name": "Epirubicin",
    "primaryCoding": "ncit:C62028",
    "mappings": [
      402
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Topoisomerase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 77,
    "conceptType": "Drug",
    "name": "Alpelisib",
    "primaryCoding": "ncit:C94214",
    "mappings": [
      403
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PI3K/AKT/mTOR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 78,
    "conceptType": "Drug",
    "name": "Selpercatinib",
    "primaryCoding": "ncit:C134987",
    "mappings": [
      404
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "RET inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 79,
    "conceptType": "Drug",
    "name": "Lenalidomide",
    "primaryCoding": "ncit:C2668",
    "mappings": [
      405
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Angiogenesis inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 80,
    "conceptType": "Drug",
    "name": "Entrectinib",
    "primaryCoding": "ncit:C114984",
    "mappings": [
      406
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ALK inhibition",
          "ROS1 inhibition",
          "NTRK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 82,
    "conceptType": "Drug",
    "name": "Midostaurin",
    "primaryCoding": "ncit:C1872",
    "mappings": [
      408
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "FLT3 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 83,
    "conceptType": "Drug",
    "name": "Asciminib",
    "primaryCoding": "ncit:C114494",
    "mappings": [
      409
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "BCR-ABL inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 84,
    "conceptType": "Drug",
    "name": "Dasatinib",
    "primaryCoding": "ncit:C38713",
    "mappings": [
      410
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "BCR-ABL inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 85,
    "conceptType": "Drug",
    "name": "Capmatinib",
    "primaryCoding": "ncit:C90564",
    "mappings": [
      411
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "MET inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 86,
    "conceptType": "Drug",
    "name": "Osimertinib",
    "primaryCoding": "ncit:C116377",
    "mappings": [
      412
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 87,
    "conceptType": "Drug",
    "name": "Talazoparib",
    "primaryCoding": "ncit:C95733",
    "mappings": [
      413
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PARP inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 88,
    "conceptType": "Drug",
    "name": "Nilotinib",
    "primaryCoding": "ncit:C48375",
    "mappings": [
      414
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "BCR-ABL inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 89,
    "conceptType": "Drug",
    "name": "Atezolizumab",
    "primaryCoding": "ncit:C106250",
    "mappings": [
      415
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PD-1/PD-L1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 90,
    "conceptType": "Drug",
    "name": "Tepotinib",
    "primaryCoding": "ncit:C88314",
    "mappings": [
      416
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "MET inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 91,
    "conceptType": "Drug",
    "name": "Azacitidine",
    "primaryCoding": "ncit:C288",
    "mappings": [
      417
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Hypomethylating agent chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 92,
    "conceptType": "Drug",
    "name": "Ivosidenib",
    "primaryCoding": "ncit:C114383",
    "mappings": [
      418
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "IDH1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 93,
    "conceptType": "Drug",
    "name": "Arsenic trioxide",
    "primaryCoding": "ncit:C1005",
    "mappings": [
      419
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PML::RARA inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 94,
    "conceptType": "Drug",
    "name": "Sacituzumab govitecan",
    "primaryCoding": "ncit:C102783",
    "mappings": [
      420
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Topoisomerase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 95,
    "conceptType": "Drug",
    "name": "Tucatinib",
    "primaryCoding": "ncit:C77896",
    "mappings": [
      421
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "HER2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 96,
    "conceptType": "Drug",
    "name": "Lapatinib",
    "primaryCoding": "ncit:C26653",
    "mappings": [
      422
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "HER2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 97,
    "conceptType": "Drug",
    "name": "Panitumumab",
    "primaryCoding": "ncit:C1857",
    "mappings": [
      423
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 98,
    "conceptType": "Drug",
    "name": "Venetoclax",
    "primaryCoding": "ncit:C103147",
    "mappings": [
      424
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "BCL2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 99,
    "conceptType": "Drug",
    "name": "Abemaciclib",
    "primaryCoding": "ncit:C97660",
    "mappings": [
      425
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "CDK4/6 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 100,
    "conceptType": "Drug",
    "name": "Larotrectinib",
    "primaryCoding": "ncit:C115977",
    "mappings": [
      426
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "NTRK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 101,
    "conceptType": "Drug",
    "name": "Dacomitinib",
    "primaryCoding": "ncit:C53398",
    "mappings": [
      427
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 102,
    "conceptType": "Drug",
    "name": "Crizotinib",
    "primaryCoding": "ncit:C74061",
    "mappings": [
      428
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ALK inhibition",
          "MET inhibition",
          "ROS1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 104,
    "conceptType": "Drug",
    "name": "Gilteritinib",
    "primaryCoding": "ncit:C116722",
    "mappings": [
      430
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "FLT3 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 105,
    "conceptType": "Drug",
    "name": "Idelalisib",
    "primaryCoding": "ncit:C78825",
    "mappings": [
      431
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PI3K/AKT/mTOR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 106,
    "conceptType": "Drug",
    "name": "Ceritinib",
    "primaryCoding": "ncit:C115112",
    "mappings": [
      432
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ALK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 107,
    "conceptType": "Drug",
    "name": "Tislelizumab",
    "primaryCoding": "ncit:C121775",
    "mappings": [
      433
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PD-1/PD-L1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 108,
    "conceptType": "Drug",
    "name": "Amivantamab",
    "primaryCoding": "ncit:C124993",
    "mappings": [
      434
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 109,
    "conceptType": "Drug",
    "name": "Capivasertib",
    "primaryCoding": "ncit:C102564",
    "mappings": [
      435
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PI3K/AKT/mTOR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 110,
    "conceptType": "Drug",
    "name": "Erdafitinib",
    "primaryCoding": "ncit:C103273",
    "mappings": [
      436
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "FGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 111,
    "conceptType": "Drug",
    "name": "Zolbetuximab",
    "primaryCoding": "ncit:C85475",
    "mappings": [
      437
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "CLDN18.2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 113,
    "conceptType": "Drug",
    "name": "Zanubrutinib",
    "primaryCoding": "ncit:C141428",
    "mappings": [
      439
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "BTK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 114,
    "conceptType": "Drug",
    "name": "Acalabrutinib",
    "primaryCoding": "ncit:C113442",
    "mappings": [
      440
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "BTK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 115,
    "conceptType": "Drug",
    "name": "Ibrutinib",
    "primaryCoding": "ncit:C81934",
    "mappings": [
      441
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "BTK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 116,
    "conceptType": "Drug",
    "name": "Ifosfamide",
    "primaryCoding": "ncit:C564",
    "mappings": [
      442
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Alkylating chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 117,
    "conceptType": "Drug",
    "name": "Vinorelbine",
    "primaryCoding": "ncit:C1275",
    "mappings": [
      443
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Vinca alkaloid chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 119,
    "conceptType": "Drug",
    "name": "Tamoxifen",
    "primaryCoding": "ncit:C62078",
    "mappings": [
      445
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Estrogen receptor inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 120,
    "conceptType": "Drug",
    "name": "Ofatumumab",
    "primaryCoding": "ncit:C66952",
    "mappings": [
      446
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "CD20 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 121,
    "conceptType": "Drug",
    "name": "Bendamustine",
    "primaryCoding": "ncit:C73261",
    "mappings": [
      447
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Alkylating chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 122,
    "conceptType": "Drug",
    "name": "Prednisone",
    "primaryCoding": "ncit:C770",
    "mappings": [
      448
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Corticosteroid"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 123,
    "conceptType": "Drug",
    "name": "Chlorambucil",
    "primaryCoding": "ncit:C362",
    "mappings": [
      449
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Alkylating chemotherapy"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 124,
    "conceptType": "Drug",
    "name": "Mitoxantrone",
    "primaryCoding": "ncit:C62050",
    "mappings": [
      450
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Topoisomerase inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 125,
    "conceptType": "Drug",
    "name": "Interferon Alpha",
    "primaryCoding": "ncit:C20494",
    "mappings": [
      451
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Cytokine stimulation"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Immunotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 126,
    "conceptType": "Drug",
    "name": "Enasidenib",
    "primaryCoding": "ncit:C111573",
    "mappings": [
      452
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "IDH2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 127,
    "conceptType": "Drug",
    "name": "Infigratinib",
    "primaryCoding": "ncit:C88302",
    "mappings": [
      453
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "FGFR2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 128,
    "conceptType": "Drug",
    "name": "Margetuximab",
    "primaryCoding": "ncit:",
    "mappings": [
      454
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ER signaling inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 129,
    "conceptType": "Drug",
    "name": "Eribulin",
    "primaryCoding": "ncit:C96748",
    "mappings": [
      455
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Tubulin polymerization inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 130,
    "conceptType": "Drug",
    "name": "Mobocertinib",
    "primaryCoding": "ncit:C126752",
    "mappings": [
      456
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 131,
    "conceptType": "Drug",
    "name": "Olutasidenib",
    "primaryCoding": "ncit:C129687",
    "mappings": [
      457
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "IDH1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 132,
    "conceptType": "Drug",
    "name": "Lenvatinib",
    "primaryCoding": "ncit:C95124",
    "mappings": [
      458
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "VEGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 133,
    "conceptType": "Drug",
    "name": "Pemigatinib",
    "primaryCoding": "ncit:C121553",
    "mappings": [
      459
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "FGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 134,
    "conceptType": "Drug",
    "name": "Repotrectinib",
    "primaryCoding": "ncit:C133821",
    "mappings": [
      460
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ROS inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 135,
    "conceptType": "Drug",
    "name": "Fludarabine",
    "primaryCoding": "ncit:C1094",
    "mappings": [
      461
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Antimetabolite"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 136,
    "conceptType": "Drug",
    "name": "Rucaparib",
    "primaryCoding": "ncit:C137800",
    "mappings": [
      462
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PARP inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 137,
    "conceptType": "Drug",
    "name": "Tazemetostat",
    "primaryCoding": "ncit:C107506",
    "mappings": [
      463
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EZH2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 138,
    "conceptType": "Drug",
    "name": "Enzalutamide",
    "primaryCoding": "ncit:C71744",
    "mappings": [
      464
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Antiandrogen"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 139,
    "conceptType": "Drug",
    "name": "Lazertinib",
    "primaryCoding": "ncit:C148147",
    "mappings": [
      465
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "EGFR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 140,
    "conceptType": "Drug",
    "name": "Mirvetuximab soravtansine",
    "primaryCoding": "ncit:C102566",
    "mappings": [
      466
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Folate receptor-alpha inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Chemotherapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 141,
    "conceptType": "Drug",
    "name": "Tovorafenib",
    "primaryCoding": "ncit:C106254",
    "mappings": [
      467
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "B-RAF inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 142,
    "conceptType": "Drug",
    "name": "Vorasidenib",
    "primaryCoding": "ncit:C152914",
    "mappings": [
      468
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "IDH1/2 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 143,
    "conceptType": "Drug",
    "name": "Goserelin",
    "primaryCoding": "ncit:C1374",
    "mappings": [
      469
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Gonadotropin-releasing hormone (GnRH) agonist"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Hormone therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 144,
    "conceptType": "Drug",
    "name": "Inavolisib",
    "primaryCoding": "ncit:C132166",
    "mappings": [
      470
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "PI3K/AKT/mTOR inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 145,
    "conceptType": "Drug",
    "name": "Zanidatamab",
    "primaryCoding": "ncit:C130010",
    "mappings": [
      471
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ER signaling inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 146,
    "conceptType": "Drug",
    "name": "Zenocutuzumab",
    "primaryCoding": "ncit:C152948",
    "mappings": [
      472
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "NRG1 inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 147,
    "conceptType": "Drug",
    "name": "Ensartinib",
    "primaryCoding": "ncit:C102754",
    "mappings": [
      473
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "ALK inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  },
  {
    "id": 148,
    "conceptType": "Drug",
    "name": "Revumenib",
    "primaryCoding": "ncit:C165776",
    "mappings": [
      474
    ],
    "extensions": [
      {
        "name": "therapy_strategy",
        "value": [
          "Menin inhibition"
        ],
        "description": "Associated therapeutic strategy or mechanism of action of the therapy."
      },
      {
        "name": "therapy_type",
        "value": "Targeted therapy",
        "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
      }
    ]
  }
]